News

Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of up to $250m.
Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...
INDIANAPOLIS and WEST LAFAYETTE, Ind. - Eli Lilly and Company (NYSE: LLY), a pharmaceutical giant with annual revenue exceeding $49 billion and an impressive 81.7% gross profit margin, and Purdue ...
Eli Lilly and Purdue University ... investment of up to $250m over the next eight years by Lilly, to expedite innovation across the pharma pipeline. The Lilly-Purdue 360 Initiative focuses ...
Eli Lilly and Co. and Purdue University announced today a significant expansion of their long-standing alliance ... innovation at every stage of the pharmaceutical pipeline.
US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, with Lilly's planned investment of up to $250 million in the collaboration ...
Eli Lilly is investing ... the Lilly and Purdue Research Alliance Center, according to the release. The long-time partners also announced the new Young Institute Pharmaceutical Manufacturing ...
The company’s market capitalization stands at $641.77 billion, reflecting its position as a prominent player in the pharmaceuticals ... Eli Lilly and Purdue University have expanded their ...
INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance ... at every ...
Sidekick is also working with a number of other pharma companies on companion ... and other chronic conditions. The new Lilly alliance is one of three that Sidekick expects to announce in the ...